Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Learn ways to boost retirement funds with simple strategies. Enhance your savings to secure a comfortable retirement.
16,711 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Institutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
U.S. GDP rose at a 1.4% annualized pace in the fourth quarter, a sharp deceleration from earlier quarters. The report...
Bitcoin liquidity tightens as the crypto native version money pool shrinks, signaling thinner market depth and sharpe...
A sharp stock drop often triggers fear, but a sizable buy can signal belief in a company’s growth path. This article ...
A respected investment firm recently disclosed a new stake in Portland General Electric, adding a signal to watch for...
RedotPay, a hong kong-based stablecoin payments company, is weighing a U.S. IPO that could raise more than $1 billion...
After a dramatic fall, Bitcoin traders expect more pain ahead as BTC slips from its peak. This guide breaks down what...
Crypto prediction markets are growing as traders bet on real-world outcomes. The space blends crypto tech with real e...
Meme coins can surprise with sudden moves, and Pepe is no exception. This article unpacks the drivers behind a sharp ...
Aptos has seen a notable price drop even with multiple upbeat developments. This deep dive explains what’s driving th...
As Friday marks the monthly expiry for a massive billion crypto options batch, traders brace for potential volatility...